<DOC>
	<DOCNO>NCT01560065</DOCNO>
	<brief_summary>Myo-Inositol ( MI ) precursor synthesis phosphatidylinositol polyphosphate ( PIPs ) . In male reproduction , show MI concentration seminiferous tubule higher serum increase movement epididymis deferent duct . In present study , role myo-inositol investigate possible antioxidant agent systemic treatment male infertility improvement sperm 's quality . Samples seminal fluid obtain two group patient undergo IVF cycle : healthy subject subject oligoasthenospermia ( OA , &lt; 15 mil/ml ) . The collected sample submit optic microscopy order evaluate semen 's volume , spermatozoon 's number motility , initial semen analysis density gradient separation method ; parameter evaluate administration 4000mg/die myo-inositol associate 400 Âµg folic acid three month . These value compare sample seminal fluid healthy patient undergo IVF cycle female cause infertility ( control group ) .</brief_summary>
	<brief_title>Effect Treatment With Myo-inositol Human Semen Parameters Patients Undergoing In Vitro Fertilization Cycles</brief_title>
	<detailed_description />
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>35 day sexual abstinence systemic endocrine disease genital infection history cryptorchidism varicocele microorchidism hormonal treatment last six month alcohol intake , cigarette smoke and/or drug abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>